Phoenix Biotech PBAX Stock
5.85 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Financial Services
INDUSTRY
Shell Companies
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
36.47M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Phoenix Biotech Price Chart
Phoenix Biotech PBAX Financial and Trading Overview
| Phoenix Biotech stock price | 5.85 USD |
| Previous Close | 10.9 USD |
| Open | 10.79 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1200 |
| Day's Range | 10.79 - 10.81 USD |
| 52 Week Range | 10.01 - 11.83 USD |
| Volume | 5.12K USD |
| Avg. Volume | 4.2K USD |
| Market Cap | 73.18M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PBAX Valuation Measures
| Enterprise Value | 73.7M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Phoenix Biotech Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 7.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.83 USD |
| 52 Week Low | 10.01 USD |
| 50-Day Moving Average | 10.81 USD |
| 200-Day Moving Average | 10.45 USD |
PBAX Share Statistics
| Avg. Volume (3 month) | 4.2K USD |
| Avg. Daily Volume (10-Days) | 820 USD |
| Shares Outstanding | 2.17M |
| Float | 1.47M |
| Short Ratio | 0.52 |
| % Held by Insiders | 32.20% |
| % Held by Institutions | 480.71% |
| Shares Short | 1.11K |
| Short % of Float | 0.069% |
| Short % of Shares Outstanding | 0.020% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -771451 USD |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 178.09K USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 650K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.382 |
| Book Value Per Share (mrq) | -1.71 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -981933 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Phoenix Biotech
| Country | United States |
| State | CA |
| City | Oakland |
| Address | 2201 Broadway |
| ZIP | 94612 |
| Phone | 215 731 9450 |
| Website | https://www.phoenixbiotechacquisitioncorp.com |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | N/A |
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
Q&A For Phoenix Biotech Stock
What is a current PBAX stock price?
Phoenix Biotech PBAX stock price today per share is 5.85 USD.
How to purchase Phoenix Biotech stock?
You can buy PBAX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phoenix Biotech?
The stock symbol or ticker of Phoenix Biotech is PBAX.
Which industry does the Phoenix Biotech company belong to?
The Phoenix Biotech industry is Shell Companies.
How many shares does Phoenix Biotech have in circulation?
The max supply of Phoenix Biotech shares is 6.23M.
What is Phoenix Biotech Price to Earnings Ratio (PE Ratio)?
Phoenix Biotech PE Ratio is 0.00000000 now.
What was Phoenix Biotech earnings per share over the trailing 12 months (TTM)?
Phoenix Biotech EPS is 0 USD over the trailing 12 months.
Which sector does the Phoenix Biotech company belong to?
The Phoenix Biotech sector is Financial Services.
Phoenix Biotech PBAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
- {{ link.label }} {{link}}